Lemonade Is So Much Better With This Ingredient From The Back Of Your Fridge

Nothing's more refreshing than a tall, cold glass of lemonade. Give this favorite beverage an unexpected jolt by adding a ...
Le Lézard

New clinical data highlights CAPLYTA® (lumateperone) as a promising option for achieving remission in adults with major depressive disorder

Johnson & Johnson today announced a new analysis of Phase 3 data which found CAPLYTA® (lumateperone), in combination with an ...
Onlymyhealth on MSN

Former VP Jagdeep Dhankhar Admitted to AIIMS Cardiology Dept After Fainting Spells

Ex-Vice President Jagdeep Dhankhar hospitalised after fainting spells at 74 Read ahead to know more about his condition and ...

BioCorRx, Inc. Announces Initiation of Clinical Study by Majority-Owned Subsidiary BioCorRx Pharmaceuticals, Inc. Evaluating Long-Acting Naltrexone Implant With or Without ...

Clinical Study Evaluating a Long-Acting Naltrexone Implant Under the FDA's 505(b)(2) Pathway ANAHEIM, CA - January 14, 2026 (NEWMEDIAWIRE) - BioCorRx Inc. (OTCID: BICX) (the "Company"), a developer ...

Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS

Travere Therapeutics, Inc., (Nasdaq: TVTX) announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for ...
PharmiWeb

Travere Therapeutics Provides Corporate Update and 2026 Outlook

U.S. FILSPARI reaches all-time highs of 908 new PSFs and net product sales of approximately $103 million in 4Q 2025Company ...